Skip to Content

Par C209 (Fenofibric Acid Delayed-Release 45 mg)

Pill with imprint Par C209 is Brown & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 45 mg. It is supplied by Par Pharmaceutical Companies, Inc..

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 45 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Par C209

Fenofibric acid delayed-release 45 mg Par C209

Fenofibric Acid Delayed-Release

Imprint
Par C209
Strength
45 mg
Color
Brown & Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical Companies, Inc.
National Drug Code (NDC)
10370-0209

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.